Conference item : Abstract
MDS-482 Impact of magrolimab in combination with azacitidine on red blood cells (RBCs) in patients with higher-risk myelodysplastic syndromes (HR MDS)
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 32.3KB, Terms of use)
-
- Publisher copy:
- 10.1016/s2152-2650(22)01421-5
Authors
- Publisher:
- Elsevier
- Journal:
- Clinical Lymphoma Myeloma and Leukemia More from this journal
- Volume:
- 22
- Issue:
- S2
- Pages:
- S317-S318
- Publication date:
- 2022-09-21
- Event title:
- Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022)
- Event location:
- Houston, Texas
- Event website:
- https://www.sohomeetings.org/event/c246685a-efe2-47de-b98e-35e1a60d0ab4/summary
- Event start date:
- 2022-09-28
- Event end date:
- 2022-10-01
- DOI:
- EISSN:
-
2152-2669
- ISSN:
-
2152-2650
- Pmid:
-
36163968
- Language:
-
English
- Keywords:
- Subtype:
-
Abstract
- Pubs id:
-
1280443
- Local pid:
-
pubs:1280443
- Deposit date:
-
2022-11-15
Terms of use
- Copyright holder:
- Elsevier Inc.
- Copyright date:
- 2022
- Rights statement:
- © 2022 Elsevier Inc. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S2152-2650(22)01421-5
If you are the owner of this record, you can report an update to it here: Report update to this record